Ranking 15th in MM&M’s Agency 100: Celebrating collaboration across our commercialization offering
7/12/2023
Avalere Health (formerly Fishawack Health) is proud to be ranked 15 in Medical, Marketing, and Media’s (MM&M) annual Agency 100 list. We are thrilled to partner with our biopharmaceutical, medical technology, and wellness clients, connecting advisory to execution capabilities. Explore what sets us apart and why better health happens when we connect.
Avalere Health (formerly Fishawack Health) has ranked 15 in MM&M’s prestigious Agency 100 list for 2023, climbing in position for the fourth year in a row. This recognition reflects our unwavering commitment to delivering exceptional services from advisory to execution, driving commercial success and improved outcomes.
Since last year’s ranking, we have continued our integration journey, bringing diverse and talented experts together in custom-built teams to provide cross-functional solutions across the product life cycle, tailored to our clients’ needs.
“The most frequent challenges in the healthcare environment today defy categorization into discrete areas of expertise. Part of our focus this upcoming year is to ensure that our processes, our talent, and our data conduits are structured in a way that allows people to easily access information and people from around the organization,” says Jon Koch, CEO.
With a focus on cooperation and advancement, this year, we bolstered our Digital Experience Technology offering. Our technologists and data analysts support teams across the business, harnessing data and technology to develop personalized, connected, and targeted experiences for healthcare stakeholders, including healthcare professionals, regulators, payers, patients, and their caregivers.
Recently, our Marketing and Medical Communications teams worked together to build the RheuMuseum, an interactive disease education concept for UCB. Just one of many examples of our interdisciplinary response to clients’ commercialization challenges, this project “blends clinical disease education and information in a really compelling creative and digital execution,” says Ryan Mason, Chief Marketing and Creative Officer.
Listen to the podcast interview
Mario Muredda, President, Marketing, and Ryan were recently featured on MM&M’s Agency 100 Studio Session podcast to discuss creating living brands that evolve with customer needs and how the intersection of creativity and technology can unlock more meaningful marketing experiences. Listen to the full episode now.
Find out what sets us apart
As our organization evolves, we remain dedicated to continuing our trajectory of growth and partnering with clients to unlock new possibilities and create a healthier future together.